Today marks the launch of a new general population survey (GPS) in Georgia, under the EMCDDA4Georgia bilateral technical cooperation project (EMCDDA4GE). The survey is in line with one of the overall goals of the project: to increase the availability of national drug-related data and statistics in the health field. The first GPS in Georgia was undertaken in 2015 and was funded by the United States Agency for International Development (USAID) and the Czech Development Agency (CzDA).
‘Prevalence and patterns of drug use’ is one of the key indicators used by the EMCDDA to assess the drug situation in Europe. It aims to improve understanding of patterns of drug use, risk perceptions, social and health correlates, as well as the consequences of the use of illicit drugs. The indicator uses a number of tools, including data from GPS, that provide an overall indication of licit and illicit drug use in a country. This can help shape future drug policies and interventions, prevention activities and better-organised primary health care services.
The GPS will be implemented by Alternative Georgia, under the supervision of the Georgian National Drug Observatory and the EMCDDA. The final results are expected in February 2023.
This webpage has been produced with the assistance of the European Union. Its contents are the sole responsibility of the EMCDDA and do not necessarily reflect the views of the European Union.
